
Xiao-hui L. Zhang
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 503 publications
A Novel Conditioning Regimen Incorporating Low-Dose Cyclophosphamide and Thiotepa for Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia at High Risk of Cardiotoxicity.
Journal: Transplantation and cellular therapy
Published: June 03, 2026
Ginsenoside Rb1 alleviates isoproterenol- and transverse aortic constriction-induced cardiac fibrosis by suppressing monocyte recruitment via targeting Raf1.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 09, 2026
The impact of pre-existing autoimmune diseases in myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective cohort study.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 10, 2026
Haploidentical allogeneic haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria: a retrospective analysis.
Journal: Annals of hematology
Published: February 13, 2026
Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplant.
Journal: Clinical and experimental medicine
Published: February 09, 2026
Incidence and risk factors of Epstein-Barr virus infection and post-transplant lymphoproliferative disorder in paediatric haploidentical allogeneic hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: February 07, 2026
The PI3K-AKT pathway mediates the imbalance of bone marrow macrophage polarization in patients with immune thrombocytopenia.
Journal: Journal of translational medicine
Published: February 05, 2026
Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: January 07, 2026
Survival benefit of allogeneic HSCT in CMML patients during the molecular stratification era.
Journal: Cancer letters
Published: December 08, 2025
Last Updated: 09/26/2026